Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Study of Efficacy and Safety of Brodalumab Compared With Placebo in Adults With Inadequately Controlled Asthma With High Bronchodilator Reversibility

ClinicalTrials.gov ID: NCT01902290

Public ClinicalTrials.gov record NCT01902290. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 10:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if brodalumab (AMG 827) is safe and effective compared to placebo as measured by change in Asthma Control Questionnaire (ACQ) composite scores.

Study identification

NCT ID
NCT01902290
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Amgen
Industry
Enrollment
421 participants

Conditions and interventions

Conditions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 22, 2013 (Actual)
Primary completion
May 15, 2015 (Actual)
Completion
May 15, 2015 (Actual)
Last update posted
Sep 21, 2022

2013 – 2015

United States locations

U.S. sites
73
U.S. states
32
U.S. cities
67
Facility City State ZIP Site status
Research Site Birmingham Alabama 35209 —
Research Site Glendale Arizona 85306 —
Research Site Phoenix Arizona 85006 —
Research Site Scottsdale Arizona 85251 —
Research Site Little Rock Arkansas 72205 —
Research Site Bakersfield California 93301 —
Research Site Encinitas California 92024 —
Research Site Los Angeles California 90025 —
Research Site Los Angeles California 90048 —
Research Site Newport Beach California 92663 —
Research Site North Hollywood California 91606 —
Research Site Orange California 92868 —
Research Site Palmdale California 93551 —
Research Site Rolling Hills Estates California 90274 —
Research Site San Diego California 92103 —
Research Site San Diego California 92108 —
Research Site San Jose California 95117 —
Research Site Santa Monica California 90404 —
Research Site Stockton California 95207 —
Research Site Colorado Springs Colorado 80907 —
Research Site Waterbury Connecticut 06708 —
Research Site Aventura Florida 33180 —
Research Site Hialeah Florida 33012 —
Research Site Jacksonville Florida 32256 —
Research Site Lynn Haven Florida 32444 —
Research Site Miami Florida 33173 —
Research Site Orlando Florida 32806 —
Research Site Port Orange Florida 32127 —
Research Site Tallahassee Florida 32308 —
Research Site Decatur Georgia 30033 —
Research Site Lawrenceville Georgia 30046 —
Research Site Eagle Idaho 83616 —
Research Site Chicago Illinois 60616 —
Research Site Chicago Illinois 60637 —
Research Site Normal Illinois 61761 —
Research Site Peoria Illinois 61603 —
Research Site Iowa City Iowa 52242 —
Research Site Paducah Kentucky 42003 —
Research Site Baltimore Maryland 21224 —
Research Site Baltimore Maryland 21236 —
Research Site North Dartmouth Massachusetts 02747 —
Research Site Plymouth Minnesota 55441 —
Research Site Jackson Mississippi 39216 —
Research Site St Louis Missouri 63110 —
Research Site Bellevue Nebraska 68123 —
Research Site Ocean City New Jersey 07712 —
Research Site Albuquerque New Mexico 87109 —
Research Site Rochester New York 14618 —
Research Site Charlotte North Carolina 28207 —
Research Site High Point North Carolina 27262 —
Research Site Winston-Salem North Carolina 27103 —
Research Site Cincinnati Ohio 45231 —
Research Site Dublin Ohio 43016 —
Research Site Middleburg Heights Ohio 44130 —
Research Site Oklahoma City Oklahoma 73103 —
Research Site Lake Oswego Oregon 97035 —
Research Site Medford Oregon 97504 —
Research Site Portland Oregon 97202 —
Research Site Upland Pennsylvania 19013 —
Research Site Rock Hill South Carolina 29732 —
Research Site Spartanburg South Carolina 29303 —
Research Site Bristol Tennessee 37620 —
Research Site Nashville Tennessee 37203-1424 —
Research Site Nashville Tennessee 37214 —
Research Site Arlington Texas 76018 —
Research Site Dallas Texas 75231 —
Research Site El Paso Texas 79903 —
Research Site McKinney Texas 75069 —
Research Site San Antonio Texas 78229 —
Research Site San Antonio Texas 78258 —
Research Site Clinton Utah 84015 —
Research Site Bellingham Washington 98225 —
Research Site Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 88 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01902290, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 21, 2022 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01902290 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →